ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Yun Ding, Liping Zhang, Lijuan Zhang, Qiaoling Zhong
Fear of disease progression is one of the most common psychological problems in the treatment of cancer patients. Early recognition and intervention can effectively control the level of fear of disease progression and improve the quality of life of patients.…
Mariam Harrak, Khouloud Ziani, Madiha Chelakhi, Othmane Saqri, Nabila Sellal, Mohamed El Hfid
Malignant tumors originating from the middle ear are rare. The literature identifies chronic inflammation and Human Papillomavirus (HPV) infection as the most common risk factors. A CT scan to assess bony invasion and an MRI to evaluate soft tissue involvemen…
Yadi Gu
Lung cancer remains a significant global health challenge and identifying lung cancer at an early stage is essential for enhancing patient outcomes. The study focuses on developing and optimizing gene expression-based models for classifying cancer types using…
Liping Zhang, Lijuan Zhang, Yun Ding, Lili Han, Jiamin Kuang, Qinghua Luo, Xinhua Xie, Zeyu Shuang, Qiaoling Zhong
Objective: To investigate the effect of surgical nursing on grade III Hand-Foot Syndrome (HFS) induced by Doxorubicin hydrochloride liposome chemotherapy after breast cancer surgery. Method : From January 2019 to December 2019, 10 patients with HFS grade III…
Cuicui Zeng, Linjuan Zeng
Aim: To study the clinical value of accelerated recovery care in pulmonary rehabilitation of perioperative lung cancer patients. Methods: 98 lung cancer patients undergoing surgery were admitted to our hospital from March 2020 to November 2021 and randomly di…
Hany S. Attallah, Radwa M. Hamed, Khaled M. EL-Shahat, Aliaa Mahmoud, Mahmoud Abdallah, Ibraheem Haggag, Emad Moustafa, Adel Yassin, 1 1
Background: The treatment of brain metastases with radiotherapy has shifted to the use of Stereotactic Radio-surgery (SRS). The technical issue of expanding the treatment volume around the Gross Tumor Volume (GTV) is a current debate. Radiotherapy centers use…
Sensuke Konno, Jonathan Wong, Andrew Penunuri, Kelvin Zheng, Muhammad Choudhury
The outcomes of chemotherapy have been unsatisfactory with the palpable side effects. We hypothesized that natural products might help improve chemotherapy with few side effects. Recently, we came across the bioactive extracts of monk fruit ( Siraitia grosven…
Rive Lukuaku Buanza, Jérémie Okumadi Lukuke, Fabrice Bokambandja Lolangwa, Andy Mbangama Muela, Matthieu Loposo Nkumu, François Beya Kabongo, Renault Kambere Sitamuina, Jean-Marie Mpolesha Kabongo
Background: Prostate cancer, the most common male cancer, represents a real public health problem in terms of its frequency and severity in different countries around the world. It disproportionately affects people of African descent wherever they live in the…
Jinlin Du, Lanlan Li, Shiqi Song, Siqin Chen, Yaxian Yang, Jian Huang
ROS1 and EGFR are primary oncogenic drivers in non-small cell lung cancer (NSCLC) pathogenesis. However, EGFR mutations and ROS1 fusions are generally mutually exclusive in NSCLC, leading to a negligible probability of their co-occurrence. Consequently, clini…
Rive Lukuaku Buanza, Jérémie Okumadi Lukuke, Fabrice Bokambandja Lolangwa, Andy Mbangama Muela, Teddy Mukendi Lwambwa, Fabrice Bumwana Ali, Sano Sire Mariama, Bleuvy-Justice Fayeta, Mardoche Binangu, Jean Isme Ngambika, David Azako Tasema, Dieudonné Mvumbi, 1 1, 1 1
<b>Background: </b>The management of breast cancer increasingly requires molecular classification based on immunohistochemistry. As breast cancer is a heterogeneous disease characterized by the accumulation of multiple molecular alterations that give each tum…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).